Revision history of "Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy" (Q34431441)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 May 2022

26 December 2021

19 May 2021

28 July 2020

23 September 2019

30 June 2019

9 June 2019

7 May 2019

15 March 2019

5 December 2018

27 October 2018

9 September 2018

6 July 2018

8 October 2017

  • curprev 09:0809:08, 8 October 2017 Emijrpbot talk contribs 41,744 bytes +4,693 Updated Item: BOT - Adding descriptions (57 languages): ar, ast, bg, bn, ca, cs, da, de, el, eo, es, et, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nl, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cy... undo (restore)

2 August 2017